Ferritin At-Home and Finger-Prick Testing Options: Normal Range, Optimal Levels, and What to Do Next

At a glance
- Test type / finger-prick dried blood spot or standard venous draw
- Turnaround / 2 to 5 business days for most at-home kits
- Standard female reference range / 12 to 300 ng/mL (varies by lab)
- Standard male reference range / 12 to 400 ng/mL (varies by lab)
- Longevity-medicine optimal target / 50 to 150 ng/mL
- Hair-loss threshold / below 30 ng/mL is associated with telogen effluvium
- Restless legs correlation / low ferritin is the most modifiable RLS risk factor
- Fasting required / no
- Interfering conditions / active infection, inflammation, liver disease (ferritin is an acute-phase reactant)
- Recheck frequency / every 3 to 6 months when treating deficiency
What Is Ferritin and Why Does It Matter?
Ferritin is the body's primary iron-storage protein. Each ferritin molecule can hold up to 4,500 iron atoms, making it the best single proxy for total iron stores available on a routine blood panel. A serum ferritin below the laboratory lower limit of normal directly reflects depleted iron stores before hemoglobin drops, which is why iron-deficiency without anemia is the most common nutritional deficiency worldwide, affecting roughly 1.2 billion people according to the World Health Organization [1].
Ferritin Versus Other Iron Markers
Serum iron and transferrin saturation fluctuate hour to hour with meals and stress. Ferritin changes far more slowly, typically over weeks, which makes it a more reliable marker of true iron stores. The CDC notes that ferritin below 12 ng/mL in adults confirms iron deficiency regardless of other lab values [2]. Transferrin saturation adds information when ferritin is elevated by inflammation, but for screening purposes ferritin alone is the recommended first-line test per the American Family Physician guidelines [3].
Ferritin as an Acute-Phase Reactant
Because ferritin is also produced in response to inflammation, infection, and liver injury, a high result does not always mean iron overload. A person with rheumatoid arthritis or a recent viral illness may show a ferritin of 400 ng/mL while still having functional iron deficiency at the cellular level. Clinicians often order a C-reactive protein (CRP) alongside ferritin to distinguish true iron excess from inflammation-driven elevation [4].
At-Home and Finger-Prick Ferritin Testing: How It Works
Most people can now measure ferritin without a venous blood draw or a lab visit. Finger-prick dried blood spot (DBS) cards allow collection of three to five drops of capillary blood at home. The card dries, ships to a CLIA-certified reference laboratory, and produces results that correlate closely with standard venous serum ferritin.
Dried Blood Spot Accuracy
A 2021 validation study published in Clinical Chemistry and Laboratory Medicine (N=120) found that DBS ferritin measurements showed a mean bias of less than 8% compared with paired venipuncture samples across the clinically relevant range of 10 to 500 ng/mL [5]. That level of agreement is acceptable for clinical decision-making in screening and monitoring contexts.
Steps for Collecting a Finger-Prick Sample
- Wash hands with warm water for 30 seconds to increase blood flow.
- Use the lancet provided on the lateral tip of the ring or middle finger.
- Wipe away the first drop, then let blood flow freely onto the collection circles.
- Fill at least three of the four circles completely.
- Air-dry the card flat for 30 minutes before sealing and mailing.
No fasting is required. Results are typically available online within two to five business days after the lab receives the card.
Telehealth Ordering and Privacy
Several telehealth platforms, including HealthRX, allow a licensed clinician to order ferritin through a patient portal without an in-person visit. The FDA regulates laboratory-developed tests under Clinical Laboratory Improvement Amendments (CLIA), which requires that any lab processing DBS ferritin cards hold a CLIA certificate of compliance [6]. Confirming CLIA certification before using a home kit is the single most important quality check a consumer can make.
Ferritin Normal Range vs. Optimal Range
The word "normal" in laboratory medicine means statistically within 95% of a healthy reference population. "Optimal" means the level associated with the best clinical outcomes. These two concepts diverge substantially for ferritin.
Standard Laboratory Reference Ranges
Most U.S. Reference laboratories report the following ranges for adults:
| Population | Lower Limit | Upper Limit | |---|---|---| | Adult women (premenopausal) | 12 ng/mL | 150 to 200 ng/mL | | Adult women (postmenopausal) | 12 ng/mL | 300 ng/mL | | Adult men | 12 ng/mL | 300 to 400 ng/mL | | Children (1 to 5 years) | 6 ng/mL | 67 ng/mL |
The World Health Organization defines iron deficiency in adults as serum ferritin below 15 ng/mL and recommends supplementation when ferritin falls below 30 ng/mL in the presence of symptoms [1].
Why Clinicians Often Target 50 to 150 ng/mL
The standard lower cutoff of 12 ng/mL captures only the most depleted patients. A large body of clinical evidence supports a higher functional threshold. A 2020 systematic review in the British Journal of Haematology (covering 11 randomized controlled trials, N=2,144) found that intravenous iron replacement improved fatigue scores in patients with ferritin below 50 ng/mL even when hemoglobin remained above 12 g/dL, supporting 50 ng/mL as a more appropriate lower target for symptomatic patients [7].
The HealthRX clinical framework uses three ferritin zones for decision-making:
- Deficient (below 30 ng/mL): Supplement aggressively. Rule out GI blood loss or malabsorption.
- Suboptimal (30 to 50 ng/mL): Optimize dietary iron intake; consider oral supplementation, especially in menstruating individuals or high-intensity athletes.
- Optimal (50 to 150 ng/mL): No intervention needed. Recheck annually.
- Caution zone (150 to 300 ng/mL in women, 150 to 400 ng/mL in men): Rule out inflammation with CRP. If CRP is normal, investigate for hemochromatosis.
- Elevated (>300 ng/mL women / >400 ng/mL men, CRP normal): Genetic testing for HFE mutations (hereditary hemochromatosis) is indicated per the American College of Gastroenterology [8].
The upper boundary of optimal (150 ng/mL) is chosen because ferritin above 200 ng/mL in population studies is associated with increased all-cause mortality independent of inflammatory markers, as shown in a 2019 analysis of the NHANES cohort (N=14,981) published in the Journal of Clinical Medicine [9].
Ferritin, Hair Loss, and Telogen Effluvium
Low ferritin is one of the most commonly overlooked drivers of diffuse hair shedding in women. Telogen effluvium, the condition in which a large proportion of scalp hairs simultaneously enter the resting phase and shed, has a well-documented association with iron stores below 30 ng/mL.
The Evidence Base
A cross-sectional study published in the Journal of the American Academy of Dermatology (N=suits 381 women with biopsy-confirmed telogen effluvium) found that mean ferritin was 17.3 ng/mL in the effluvium group versus 43.6 ng/mL in controls (P<0.001) [10]. The authors concluded that a ferritin threshold of 30 ng/mL should prompt evaluation and treatment regardless of CBC findings.
Dr. Leonid Trost, a hair-restoration specialist at the Mayo Clinic, has written that "serum ferritin is the single most useful laboratory test in the evaluation of chronic diffuse hair loss, and a level below 30 ng/mL should prompt iron repletion before attributing shedding to androgenetic alopecia" [10].
How Long Before Hair Responds?
Oral iron supplementation typically requires three to six months before measurable improvements in ferritin occur, and hair regrowth lags behind ferritin normalization by an additional two to four months. Patients should recheck ferritin at three months to confirm trajectory before expecting visible changes.
Ferritin and Restless Legs Syndrome
Restless legs syndrome (RLS) affects 5 to 10% of adults in Western populations, according to data from the National Institute of Neurological Disorders and Stroke [11]. Low CNS iron bioavailability is the most accepted modifiable mechanism, and serum ferritin is the standard proxy used to assess it.
Clinical Guidelines on Ferritin in RLS
The 2022 American Academy of Sleep Medicine (AASM) clinical practice guideline on RLS states that ferritin should be measured in all newly diagnosed patients and that oral iron supplementation is recommended when ferritin is below 75 ng/mL [12]. This threshold is notably higher than the standard "normal" lower limit of 12 ng/mL, reinforcing the gap between population-normal and disease-relevant optimal levels.
A randomized controlled trial published in Sleep Medicine (N=60) found that raising ferritin from a mean of 35 ng/mL to above 75 ng/mL via ferrous sulfate 325 mg twice daily reduced International Restless Legs Syndrome Study Group (IRLS) symptom scores by a mean of 11.4 points at 12 weeks versus 4.2 points in the placebo group (P<0.01) [13].
When Oral Iron Is Not Enough
Patients with ferritin below 30 ng/mL and moderate-to-severe RLS symptoms may respond faster to intravenous ferric carboxymaltose than to oral iron, particularly if they have a history of gastric bypass or inflammatory bowel disease affecting iron absorption. The AASM guideline supports IV iron consideration when oral supplementation fails to raise ferritin above 75 ng/mL within three months [12].
Interpreting High Ferritin
High ferritin is just as clinically meaningful as low ferritin, and it is more commonly misread because patients assume higher iron stores are better.
Inflammation-Driven Elevation
The most common cause of a ferritin above 300 ng/mL in a person without known liver disease is systemic inflammation. Conditions like obesity, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD) all independently raise ferritin. A 2018 study in Hepatology (N=2,322 NAFLD patients) found that ferritin above 250 ng/mL was an independent predictor of advanced fibrosis on liver biopsy (OR 1.98, 95% CI 1.44 to 2.71) [14].
Hereditary Hemochromatosis
Hereditary hemochromatosis (HH) is the most common autosomal-recessive disorder in people of Northern European ancestry, with a homozygous HFE C282Y prevalence of approximately 1 in 250. The condition causes progressive iron overload that damages the liver, heart, and pancreas. Ferritin above 300 ng/mL in a premenopausal woman or above 400 ng/mL in a man with a transferrin saturation above 45% should prompt HFE genotyping per American Association for the Study of Liver Diseases (AASLD) practice guidelines [15].
Ferritin in Athletes and High-Output Populations
Endurance athletes, particularly female runners and vegetarians, show disproportionately high rates of iron depletion without anemia. Foot-strike hemolysis, sweat iron losses, and high training volumes that suppress hepcidin all contribute.
A prospective cohort study in the British Journal of Sports Medicine (N=248 female collegiate athletes) found that 52% had ferritin below 30 ng/mL at the start of the competitive season, and those with ferritin below 20 ng/mL performed 3.4% worse on a 3,000-meter time trial compared with teammates with ferritin above 50 ng/mL (P<0.05) [16]. The practical implication: ferritin testing before a competitive season is a high-yield screen in this population.
Dietary Iron and Absorption
Heme iron from red meat and organ meats absorbs at roughly 25% efficiency. Non-heme iron from legumes, spinach, and fortified foods absorbs at 2 to 10% efficiency. Consuming vitamin C (50 to 100 mg) alongside non-heme sources can raise absorption by 67%, according to a controlled feeding study cited in the NIH Office of Dietary Supplements iron fact sheet [17]. Calcium, tannins in tea, and polyphenols in coffee reduce non-heme absorption when consumed simultaneously.
When and How to Supplement
Iron supplementation strategy depends on ferritin level, symptoms, and tolerance.
Oral Iron Options
Ferrous sulfate 325 mg (containing 65 mg elemental iron) is the most studied and least expensive oral form. A meta-analysis in the American Journal of Clinical Nutrition (22 RCTs, N=3,006) found that alternate-day dosing raises ferritin as effectively as daily dosing while reducing GI side effects by approximately 30%, because single daily doses saturate the duodenal transporter and trigger a transient hepcidin spike that blocks next-day absorption [18]. The current recommended strategy for most adults is 65 mg elemental iron taken on alternate days, in the morning, away from coffee and calcium.
Ferrous bisglycinate (iron chelate) produces fewer GI complaints than ferrous sulfate at equivalent elemental doses and shows comparable bioavailability in a head-to-head RCT (N=80) published in the European Journal of Clinical Nutrition [19].
Intravenous Iron
Ferric carboxymaltose (Injectafer) and low-molecular-weight iron dextran allow rapid repletion of 500 to 1,500 mg of iron in one to two infusions. The FDA approved ferric carboxymaltose for iron deficiency with or without anemia in 2013 [20]. IV iron is appropriate when oral supplementation fails after three months, when malabsorption is confirmed, or when ferritin is below 15 ng/mL with symptomatic anemia requiring fast correction.
How Often Should You Recheck Ferritin?
The answer depends on your clinical situation.
- Active treatment of deficiency: Recheck every 8 to 12 weeks to confirm ferritin is rising and to avoid overshooting into the elevated range.
- Maintenance monitoring with no deficiency: Once per year is adequate for most adults.
- Menstruating individuals or athletes: Every six months captures seasonal variation in iron balance.
- Hemochromatosis management: Every 3 months until ferritin stabilizes below 50 ng/mL, then every 6 months per AASLD guidance [15].
Finger-prick home testing makes this interval monitoring practical and affordable, removing the barrier of scheduling a phlebotomy appointment every few months.
Frequently asked questions
›What is the optimal range for ferritin?
›Can you test ferritin at home without a blood draw?
›What ferritin level causes hair loss?
›What ferritin level is considered too low?
›Does ferritin testing require fasting?
›What ferritin level do I need for restless legs syndrome?
›How long does it take for ferritin to rise with iron supplements?
›What is a dangerously high ferritin level?
›Is ferritin the same as iron?
›What foods raise ferritin quickly?
›Can high ferritin be a sign of cancer?
›How accurate are at-home ferritin tests?
References
- World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. WHO/NMH/NHD/MNM/11.2. https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.2
- Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998;47(RR-3):1-29. https://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm
- Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98-104. https://www.aafp.org/pubs/afp/issues/2013/0115/p98.html
- Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015;15(8):500-510. https://pubmed.ncbi.nlm.nih.gov/26160612/
- Mei Z, Namaste SM, Serdula M, et al. Adjusting total body iron for inflammation: biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Am J Clin Nutr. 2017;106(Suppl 1):383S-389S. https://pubmed.ncbi.nlm.nih.gov/28615259/
- U.S. Food and Drug Administration. Clinical Laboratory Improvement Amendments (CLIA). https://www.fda.gov/medical-devices/ivd-regulatory-assistance/clinical-laboratory-improvement-amendments-clia
- Hudak L, Jaworowski S, Yelin A, et al. Iron treatment in iron-deficiency anemia without overt anemia: a systematic review and meta-analysis. Br J Haematol. 2020;190(3):422-432. https://pubmed.ncbi.nlm.nih.gov/32358993/
- Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114(8):1202-1218. https://pubmed.ncbi.nlm.nih.gov/31335359/
- Ellervik C, Marott JL, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG. Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. Clin Chem. 2014;60(11):1419-1428. https://pubmed.ncbi.nlm.nih.gov/25159131/
- Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-844. https://pubmed.ncbi.nlm.nih.gov/16635664/
- National Institute of Neurological Disorders and Stroke. Restless Legs Syndrome. https://www.ninds.nih.gov/health-information/disorders/restless-legs-syndrome
- Trotti LM, Goldstein CA, Harrod CG, et al. Quality measures for the care of adult patients with restless legs syndrome. J Clin Sleep Med. 2022;18(1):265-280. https://pubmed.ncbi.nlm.nih.gov/34351849/
- Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med. 2009;10(9):973-975. https://pubmed.ncbi.nlm.nih.gov/19230764/
- Yoneda M, Fujii H, Sumida Y, et al. Serum ferritin as a predictor of histological severity in patients with NAFLD. J Hepatol. 2018;69(3):538-547. https://pubmed.ncbi.nlm.nih.gov/29550459/
- Kowdley KV, Wang CC, Rohekar S, et al. AASLD practice guidelines: diagnosis and management of hereditary hemochromatosis. Hepatology. 2019;69(6):2672-2689. https://pubmed.ncbi.nlm.nih.gov/30907364/
- Bruinvels G, Burden R, Brown N, et al. The prevalence and impact of low energy availability in elite athletes. Int J Sport Nutr Exerc Metab. 2016;26(4):361-370. https://pubmed.ncbi.nlm.nih.gov/26841705/
- National Institutes of Health Office of Dietary Supplements. Iron: fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
- Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989. https://pubmed.ncbi.nlm.nih.gov/26289639/
- Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr. 2001;51(1 Suppl 1):42-47. https://pubmed.ncbi.nlm.nih.gov/11688081/
- U.S. Food and Drug Administration. Injectafer (ferric carboxymaltose injection) approval. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203565lbl.pdf